Please provide your email address to receive an email when new articles are posted on . Cycle Pharmaceuticals announced that the FDA has approved its Tascenso ODT, a bioequivalent to Gilenya, or ...

Officials with the FDA have approved the first generic robenacoxib tablets for the control of postoperative pain and ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a 33% smaller dose of the estradiol transdermal system for the prevention of postmenopausal ...

Tascenso ODT is a sphingosine 1-phosphate receptor modulator. Tascenso ODT ®, an orally disintegrating formulation of fingolimod, has been made available by Cycle Pharmaceuticals. The product is ...

The US regulator has determined the approved Topiramate capsules USP, 15 mg and 25 mg to be bioequivalent and therapeutically equivalent to Topamax Capsules, 15 mg and 25 mg of Janssen Pharmaceuticals ...

Over the last couple years, there have been several major instances of popular generics failing to prove bioequivalent to the brand name they’re based on. Blockbuster brand-name drugs may make the ...

Although intravenous (IV) corticosteroid is standard therapy for acute optic neuritis (ON), it was unclear whether a bioequivalent dose of oral corticosteroid would be as effective. The oral route of ...

The Food and Drug Administration (FDA) announced a proposal to withdraw the approval of two generic versions of Concerta (methylphenidate HCl; Janssen) extended-release capsules indicated for ...

The FDA has approved pergolide tablets (Zygolide; Dechra) for controlling clinical signs associated with pituitary pars intermedia dysfunction (PPID) in horses, also known as equine Cushing disease.